FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2263073744> ?p ?o ?g. }

• W2263073744 endingPage "e1093721" @default.
• W2263073744 startingPage "e1093721" @default.
• W2263073744 abstract "Missing self recognition makes cancer sensitive to natural killer cell (NKc) reactivity. However, this model disregards the NKc licensing effect, which highly increases NKc reactivity through interactions of inhibitory killer cell immunoglobulin-like receptors (iKIR) with their cognate HLA-I ligands. The influence of iKIR/HLA-ligand (HLA-C1/C2) licensing interactions on the susceptibility to and progression of plasma cell (PC) dyscrasias was evaluated in 164 Caucasian patients and 286 controls. Compared to controls, myeloma accumulates KIR2DL1−L2+L3− genotypes (2.8% vs. 13.2%, p < 0.01, OR = 5.29) and less diverse peripheral repertoires of NKc clones. Less diverse and weaker-affinity repertoires of iKIR2D/HLA-C licensing interactions increased myeloma susceptibility. Thus, the complete absence of conventional iKIR2D/HLA-C licensing interactions (KIR2DL1−L2+L3−/C2C2, 2.56% vs. 0.35%; p < 0.05; OR = 15.014), single-KIR2DL3+/C1+ (20.51% vs. 10.84%; p < 0.05; OR = 2.795) and single-KIR2DL2+/C1+ (12.82% vs. 4.9%; p < 0.01; OR = 5.18) interactions were over-represented in myeloma, compared to controls. Additionally, KIR2DL1−L2+L3− (20% vs. 83%, p < 0.00001) as well as KIR3DL1− (23% vs. 82%, p < 0.00001) genotypes had a dramatic negative impact on the 3-y progression-free survival (PFS), particularly in patients with low-tumor burden. Remarkably, myeloma-PCs, compared to K562 and other hematological cancers, showed substantial over-expression of HLA-I (“increasing-self” instead of missing-self), including HLA-C, and mild expression of ligands for NKc activating receptors (aRec) CD112, CD155, ULBP-1 and MICA/B, which apparently renders myeloma-PCs susceptible to lysis mainly by licensed NKc. KIR2DL1−L2+L3−/C2C2 patients (with no conventional iKIR2D/HLA-C licensing interactions) lyse K562 but barely lyse myeloma-PCs (4% vs. 15%; p < 0.05, compared to controls). These results support a model where immunosurveillance of no-missing-self cancers, e.g., myeloma, mainly depends on NKc licensing." @default.
• W2263073744 created "2016-06-24" @default.
• W2263073744 creator A5005801792 @default.
• W2263073744 creator A5006549736 @default.
• W2263073744 creator A5011764477 @default.
• W2263073744 creator A5011816951 @default.
• W2263073744 creator A5016229824 @default.
• W2263073744 creator A5016949143 @default.
• W2263073744 creator A5018053127 @default.
• W2263073744 creator A5020245833 @default.
• W2263073744 creator A5020532486 @default.
• W2263073744 creator A5024830784 @default.
• W2263073744 creator A5025132019 @default.
• W2263073744 creator A5039768299 @default.
• W2263073744 creator A5047790411 @default.
• W2263073744 creator A5054475031 @default.
• W2263073744 creator A5059311375 @default.
• W2263073744 creator A5063809166 @default.
• W2263073744 creator A5070015589 @default.
• W2263073744 creator A5086236489 @default.
• W2263073744 creator A5088403134 @default.
• W2263073744 date "2015-10-29" @default.
• W2263073744 modified "2023-10-15" @default.
• W2263073744 title "Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing" @default.
• W2263073744 cites W1495399046 @default.
• W2263073744 cites W1523141320 @default.
• W2263073744 cites W1553417841 @default.
• W2263073744 cites W1886702016 @default.
• W2263073744 cites W1962349010 @default.
• W2263073744 cites W1963309870 @default.
• W2263073744 cites W1966185020 @default.
• W2263073744 cites W1980701461 @default.
• W2263073744 cites W1989712520 @default.
• W2263073744 cites W1992508362 @default.
• W2263073744 cites W2008919922 @default.
• W2263073744 cites W2009822105 @default.
• W2263073744 cites W2010181990 @default.
• W2263073744 cites W2012665806 @default.
• W2263073744 cites W2017568647 @default.
• W2263073744 cites W2018799866 @default.
• W2263073744 cites W2023622887 @default.
• W2263073744 cites W2023772537 @default.
• W2263073744 cites W2032292023 @default.
• W2263073744 cites W2032992208 @default.
• W2263073744 cites W2039084448 @default.
• W2263073744 cites W2039638023 @default.
• W2263073744 cites W2046318407 @default.
• W2263073744 cites W2048245039 @default.
• W2263073744 cites W2059378562 @default.
• W2263073744 cites W2062581776 @default.
• W2263073744 cites W2066269914 @default.
• W2263073744 cites W2073989522 @default.
• W2263073744 cites W2084292672 @default.
• W2263073744 cites W2085353406 @default.
• W2263073744 cites W2088513299 @default.
• W2263073744 cites W2098130458 @default.
• W2263073744 cites W2099126386 @default.
• W2263073744 cites W2104420277 @default.
• W2263073744 cites W2104689649 @default.
• W2263073744 cites W2106101491 @default.
• W2263073744 cites W2120474651 @default.
• W2263073744 cites W2130649175 @default.
• W2263073744 cites W2131189233 @default.
• W2263073744 cites W2141221280 @default.
• W2263073744 cites W2144201925 @default.
• W2263073744 cites W2144728882 @default.
• W2263073744 cites W2146366329 @default.
• W2263073744 cites W2152105313 @default.
• W2263073744 cites W2153989399 @default.
• W2263073744 cites W2155690142 @default.
• W2263073744 cites W2156381278 @default.
• W2263073744 cites W2159849043 @default.
• W2263073744 cites W2162962689 @default.
• W2263073744 cites W2163528978 @default.
• W2263073744 cites W2163941973 @default.
• W2263073744 cites W2164753292 @default.
• W2263073744 cites W2170069789 @default.
• W2263073744 cites W4252175385 @default.
• W2263073744 doi "https://doi.org/10.1080/2162402x.2015.1093721" @default.
• W2263073744 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4839374" @default.
• W2263073744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27141379" @default.
• W2263073744 hasPublicationYear "2015" @default.
• W2263073744 type Work @default.
• W2263073744 sameAs 2263073744 @default.
• W2263073744 citedByCount "16" @default.
• W2263073744 countsByYear W22630737442016 @default.
• W2263073744 countsByYear W22630737442017 @default.
• W2263073744 countsByYear W22630737442018 @default.
• W2263073744 countsByYear W22630737442019 @default.
• W2263073744 countsByYear W22630737442020 @default.
• W2263073744 countsByYear W22630737442021 @default.
• W2263073744 countsByYear W22630737442022 @default.
• W2263073744 countsByYear W22630737442023 @default.
• W2263073744 crossrefType "journal-article" @default.
• W2263073744 hasAuthorship W2263073744A5005801792 @default.
• W2263073744 hasAuthorship W2263073744A5006549736 @default.
• W2263073744 hasAuthorship W2263073744A5011764477 @default.
• W2263073744 hasAuthorship W2263073744A5011816951 @default.

• next